Health ❯ Research ❯ Clinical Research

Drug Development

Phase 3 Trials Clinical Trials Alzheimer's Treatments Combination Therapies Matrix Metalloproteinase Inhibitors Monoclonal Antibodies

Alzheimer’s Social Memory Loss Linked to Perineuronal Net Breakdown in Mice

Researchers report delayed deficits after blocking matrix metalloproteinases in a mouse model, suggesting a non-amyloid route for future treatment.

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

New Oral β2 Agonist Preserves Muscle in Early Weight-Loss Trials